Post Marketing Study on Pluvicto in Korea

Clinical trial NCT06514521 · RECRUITING

Trial details

NCT number: NCT06514521
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2025-04-18
Primary completion: 2028-05-31
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.